ACADIA Pharmaceuticals Inc.'s (ACAD) Management Presents at 2020 Stifel Virtual Healthcare Conference (Transcript)Seeking Alpha • 11/18/20
Acadia Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020Business Wire • 11/10/20
ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Steve Davis on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/05/20
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials on Alzheimer's Disease (CTAD) ConferenceBusiness Wire • 10/26/20
Acadia Pharmaceuticals to Announce Third Quarter 2020 Financial Results on November 4, 2020Business Wire • 10/21/20
Acadia Pharmaceuticals Appoints Elizabeth Garofalo, M.D. to Board of DirectorsBusiness Wire • 10/01/20
ACADIA Pharmaceuticals, Inc. (ACAD) CEO Steve Davis Presents at Cantor Virtual Global Healthcare Conference (Transcript)Seeking Alpha • 09/16/20
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/14/20
(ACAD) Alert: Johnson Fistel Announces Shareholder Class Action Against ACADIA Pharmaceuticals Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses?PRNewsWire • 09/05/20
Acadia (ACAD) Down 12% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 09/04/20
ACADIA Pharmaceuticals Appoints Gudarz Davar, M.D., as Executive Vice President and Head of Research and DevelopmentBusiness Wire • 08/31/20
ACADIA Pharmaceuticals Acquires CerSci Therapeutics, Adds Novel Pain Program to PortfolioBusiness Wire • 08/25/20
ACADIA Pharmaceuticals to Present at The JMP Securities CNS Forum on August 19, 2020Business Wire • 08/12/20